Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Sable Expands Cu-Au Footprint and Identifies New Copper and Gold Targets Ahead of Maiden Drill Program at the Zorro Project, San Juan, Argentina
-
Nephros Announces Inclusion in the Russell Microcap® Index
-
Grey Matters Takes Delivery of the First Brain Dedicated PET Scanning System for its Flagship NovaScan Neuroimaging Clinic in Florida
-
NN, Inc. Announces Major Breakthrough in its Medical Business
-
Can-Fite Achieves Key Pivotal Phase 3 Psoriasis Milestone with Completion of Patient Enrolment for the Interim Analysis: Data Expected Q4 2026/Q1 2027
-
Aurora Mobile’s JPush Partners with Pobo Financial to Build a Low-Latency, Highly Reliable Financial Information Distribution Channel
-
Belite Bio Announces Oral Presentations at Two Upcoming Medical Conferences
-
Seer Files Investor Presentation Highlighting Strong Momentum, Commercial Opportunity and Significant Long-Term Value Creation Potential
-
Wrap Technologies Receives Historic ATF Ruling Formally Classifying BolaWrap® 150 as an Instrument of Restraint — Not a Firearm or Weapon Under Federal Law
-
Brunswick Exploration Launches Summer Drill Program Targeting Mirage and Anatacau
-
Descartes Acquires Drivin
-
NovMetaPharma and the FSHD Canada Foundation Establish Collaboration to Advance Cyclo-Z, a First-in-Class Oral Muscle-Preserving Therapy, into Facioscapulohumeral Muscular Dystrophy
-
Blancco Leaders to Speak at Mobile Disrupt on Secondary Market Growth and AI Driven Margins
-
VERAXA Biotech Provides Business Update and Further Details on Partnering Strategy and Development Timelines
-
Quantum Cyber Addresses Short Seller Biased Report
-
YieldMax® ETFs Announces Distributions on MSST, NVIT, and TEST
-
Silicon Valley’s $5b AI Mega-Round Opens to European Capital Via SW Trading
-
Share buy-back program
-
Pharvaris Announces FDA Acceptance of New Drug Application for Deucrictibant IR for On-Demand Treatment of Hereditary Angioedema Attacks
-
IP Strategy Publishes Monthly Validator Update
-
LYB to discuss second-quarter results Friday, July 31, 2026
-
Parsons Pioneering Integrated Technology Solutions for PFAS Remediation
-
Novo Nordisk A/S - share repurchase programme
-
Heineken N.V. reports the progress of transactions under its current share buyback programme
-
Trinity Legal Academy Limited Introduces Cross-Border Legal Qualification Training for Mid-Career Professionals
-
Dimensional Fund Advisors Ltd. : Form 8.3 - GAMMA COMMUNICATIONS PLC - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - DCC PLC - Ordinary Shares
-
AL Sydbank A/S share buyback programme: transactions in week 27
-
Heineken Holding N.V. reports transactions under its current share buyback programme
-
Scilex Holding Company Announces Signing of Binding Term Sheet for Proposed $100 Million Strategic Investment from iHolding Group LLP
-
Radware Schedules Conference Call for Its Second Quarter 2026 Earnings
-
AtaiBeckley Doses Last Patient in VLS-01 Phase 2b TRD Study; Plans Phase 3 in Major Depressive Disorder
-
Immuron Advances IMM-529 (Clostridioides difficile infection) Partnering Strategy
-
KBR to Hold Second Quarter Earnings Conference Call
-
Nexans and Hydro secure long-term low-carbon aluminium supply agreement to support Europe’s grid modernisation
-
Pensacola Tragedy a Heartbreaking Reminder of the Importance of Community, Says Attorney Troy A. Rafferty – Rafferty Domnick Cunningham & Yaffa
-
Man Group PLC : Form 8.3 - Senior plc
-
Man Group PLC : Form 8.3 - JTC Plc
-
Man Group PLC : Form 8.3 - Gamma Communications Plc
-
Man Group PLC : Form 8.3 - DCC Plc
-
Dassault Systèmes: declaration of the number of outstanding shares and voting rights as of June 30, 2026
-
Transactions in connection with share buy-back program
-
Admission of Further Securities to Trading
-
Director/PDMR Shareholding
-
Net Asset Value
-
Criminal IP Announces Availability of Threat Intelligence Integration with OpenCTI Platform
-
Criminal IP Announces Availability of Threat Intelligence Integration with OpenCTI Platform
-
Form 8.5 (EPT/RI)-Gamma Communications Plc
-
Form 8.5 (EPT/RI) - Pharos Energy Plc
-
Form 8.5 (EPT/RI) - Kore Potash Plc
